Description
| Product Name | CAT.No | Size |
| HAV.IgG | BXE0601A | 96T |
| HAV.IgM | BXE0602A | 96T |
Product Description
The Biorex Diagnostics HAV ELISA kits are highly sensitive and specific microplate enzyme immunoassays (ELISA) designed for the qualitative detection of antibodies to human hepatitis A virus (HAV) in human serum or plasma. HAV is a single-stranded RNA virus and a major cause of acute viral hepatitis worldwide. Transmission typically occurs via the fecal-oral route, contaminated food, water, or close contact with infected individuals. Early and accurate detection of HAV antibodies is essential for identifying recent or past infection, evaluating immunity following vaccination, and supporting public health surveillance and outbreak control efforts.
Key Features
- Qualitative Microplate ELISA – enables reliable detection of HAV-specific IgG and IgM antibodies.
- High Sensitivity and Specificity – ensures accurate identification of physiologically and clinically relevant antibody levels.
- Serum and Plasma Compatibility – suitable for routine clinical diagnostic workflows.
- Reproducible Results – consistent assay performance ensures dependable outcomes across multiple runs.
- Ready-to-Use Kit Components – includes pre-formulated reagents, standards, and controls for efficient laboratory use.
- Clinical and Research Utility – supports acute infection diagnosis, immunity evaluation, outbreak monitoring, and epidemiological studies.
The Biorex Diagnostics HAV ELISA kits provide a trusted, efficient, and clinically relevant solution for laboratories and healthcare providers. By enabling precise and reproducible measurement of HAV antibodies, the kits support early detection of infection, assessment of vaccination response, and monitoring of population-level immunity. Their standardized microplate format allows for high-throughput screening and consistent laboratory workflow, making them suitable for both diagnostic and research applications. Additionally, these kits serve as valuable tools in public health programs, assisting in tracking virus prevalence, guiding outbreak response, and informing preventative strategies. Overall, the Biorex Diagnostics HAV ELISA kits contribute to improved patient care, timely clinical decisions, and enhanced understanding of hepatitis A virus infection, providing reliable support for clinicians, laboratories, and epidemiologists alike.
Contact Us for more information.